Catalan Institute of Oncology — Barcelona

Public research footprint of Catalan Institute of Oncology, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Brain Metastases From Non-small Cell Lung Cancer (NSCLC) · Melanoma · Head and Neck Squamous Cell Carcinoma · Diffuse Large B Cell Lymphoma

Recently updated registry entries

NCT06465069 — A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or… (Recruiting)
NCT07219459 — Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in… (Recruiting)
NCT04104776 — A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Catalan Institute of Oncology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.